Clover Biopharmaceuticals Ltd. Financial Overview
Clover Biopharmaceuticals Ltd.'s market cap is currently HK$3.48B. The company's EPS TTM is HK$-0.086; its P/E ratio is -3.23; Clover Biopharmaceuticals Ltd. is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
